Ligand Pharmaceuticals (LGND) Change in Receivables (2010 - 2026)
Ligand Pharmaceuticals recorded quarterly Change in Receivables of -$6.4 million in Q1 2026, down 407.09% quarter-over-quarter from $2.1 million in Q4 2025, and down 1212.67% year-over-year from $576000.0 in Q1 2025.
Ligand Pharmaceuticals' Change in Receivables history runs 17 years deep, the most recent figure standing at -$6.4 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 1212.67% year-over-year to -$6.4 million; the TTM figure through Mar 2026 stood at $14.8 million (up 40.54% YoY), while the FY2025 annual figure was $21.7 million, up 236.54% from the prior year.
- Change in Receivables came in at -$6.4 million for Q1 2026 at Ligand Pharmaceuticals, down from $2.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $20.4 million in Q2 2022 to a low of -$43.6 million in Q1 2022.
- A 5-year average of -$1.8 million and a median of $576000.0 in 2025 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables tumbled 1709.95% in 2022 and jumped 757.15% in 2024, its largest moves.
- Ligand Pharmaceuticals' Change in Receivables stood at -$34.8 million in 2022, then surged by 91.85% to -$2.8 million in 2023, then surged by 299.82% to $5.7 million in 2024, then slumped by 63.16% to $2.1 million in 2025, then tumbled by 407.09% to -$6.4 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$6.4 million, $2.1 million, and $16.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Ligand Pharmaceuticals | 4.55 Bn | 3.77 Bn | 48.45 Mn | -6.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.41 Mn |
| Mar 31, 2026 | -6.41 Mn |
| Dec 31, 2025 | 2.09 Mn |
| Dec 31, 2025 | 2.09 Mn |
| Sep 30, 2025 | 16.31 Mn |
| Sep 30, 2025 | 16.31 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Mar 31, 2025 | 576,000.00 |
| Mar 31, 2025 | 576,000.00 |
| Dec 31, 2024 | 5.67 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | -4.79 Mn |
| Sep 30, 2024 | -4.79 Mn |
| Jun 30, 2024 | 9.05 Mn |
| Jun 30, 2024 | 9.05 Mn |
| Mar 31, 2024 | -3.46 Mn |
| Mar 31, 2024 | -3.46 Mn |
| Dec 31, 2023 | -2.84 Mn |
| Dec 31, 2023 | -2.84 Mn |
| Sep 30, 2023 | 7.91 Mn |
| Sep 30, 2023 | 7.91 Mn |
| Jun 30, 2023 | -1.38 Mn |
| Jun 30, 2023 | -1.38 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -34.77 Mn |
| Dec 31, 2022 | -34.77 Mn |
| Sep 30, 2022 | 2.66 Mn |
| Sep 30, 2022 | 2.66 Mn |
| Jun 30, 2022 | 20.43 Mn |
| Jun 30, 2022 | 20.43 Mn |
| Mar 31, 2022 | -43.64 Mn |
| Mar 31, 2022 | -43.64 Mn |
| Dec 31, 2021 | 19.78 Mn |
| Dec 31, 2021 | 19.78 Mn |
| Sep 30, 2021 | 6.18 Mn |
| Sep 30, 2021 | 6.18 Mn |
| Jun 30, 2021 | 5.07 Mn |
| Jun 30, 2021 | 5.07 Mn |
| Mar 31, 2021 | -2.41 Mn |
| Mar 31, 2021 | -2.41 Mn |
| Dec 31, 2020 | 20.98 Mn |
| Dec 31, 2020 | 20.98 Mn |
| Sep 30, 2020 | -6.39 Mn |
| Sep 30, 2020 | -6.39 Mn |
| Jun 30, 2020 | 3.07 Mn |
| Jun 30, 2020 | 3.07 Mn |
| Mar 31, 2020 | 8.40 Mn |
| Mar 31, 2020 | 8.40 Mn |
| Dec 31, 2019 | 8.43 Mn |
| Dec 31, 2019 | 8.43 Mn |
| Sep 30, 2019 | 1.70 Mn |
| Sep 30, 2019 | 1.70 Mn |
| Jun 30, 2019 | -6.36 Mn |
| Jun 30, 2019 | -6.36 Mn |
| Mar 31, 2019 | -29.24 Mn |
| Mar 31, 2019 | -29.24 Mn |
| Dec 31, 2018 | 8.16 Mn |
| Dec 31, 2018 | 8.16 Mn |
| Sep 30, 2018 | 4.98 Mn |
| Sep 30, 2018 | 4.98 Mn |
| Jun 30, 2018 | 4.89 Mn |
| Jun 30, 2018 | 4.89 Mn |
| Mar 31, 2018 | 11.51 Mn |
| Mar 31, 2018 | 11.51 Mn |
| Dec 31, 2017 | 10.27 Mn |
| Dec 31, 2017 | 10.27 Mn |
| Sep 30, 2017 | -646,000.00 |
| Sep 30, 2017 | -646,000.00 |
| Jun 30, 2017 | 6.38 Mn |
| Jun 30, 2017 | 6.38 Mn |
| Mar 31, 2017 | -7.64 Mn |
| Mar 31, 2017 | -7.64 Mn |
| Dec 31, 2016 | 8.11 Mn |
| Dec 31, 2016 | 8.11 Mn |
| Sep 30, 2016 | -3.38 Mn |
| Sep 30, 2016 | -3.38 Mn |
| Jun 30, 2016 | -1.81 Mn |
| Jun 30, 2016 | -1.81 Mn |
| Mar 31, 2016 | 5.60 Mn |
| Mar 31, 2016 | 5.60 Mn |
| Dec 31, 2015 | 653,000.00 |
| Dec 31, 2015 | 653,000.00 |
| Sep 30, 2015 | -40,000.00 |
| Sep 30, 2015 | -40,000.00 |
| Jun 30, 2015 | -1.89 Mn |
| Jun 30, 2015 | -1.89 Mn |
| Mar 31, 2015 | -5.21 Mn |
| Mar 31, 2015 | -5.21 Mn |
| Dec 31, 2014 | 6.82 Mn |
| Dec 31, 2014 | 6.82 Mn |
| Sep 30, 2014 | 2.68 Mn |
| Sep 30, 2014 | 2.68 Mn |
| Jun 30, 2014 | -1.54 Mn |
| Jun 30, 2014 | -1.54 Mn |
| Mar 31, 2014 | 2.45 Mn |
| Mar 31, 2014 | 2.45 Mn |
| Dec 31, 2013 | -3.29 Mn |
| Dec 31, 2013 | -3.29 Mn |
| Sep 30, 2013 | 4.81 Mn |
| Sep 30, 2013 | 4.81 Mn |
| Jun 30, 2013 | -3.92 Mn |
| Jun 30, 2013 | -3.92 Mn |
| Mar 31, 2013 | 33,000.00 |
| Mar 31, 2013 | 33,000.00 |
| Dec 31, 2012 | 2.43 Mn |
| Dec 31, 2012 | 2.43 Mn |
| Sep 30, 2012 | 1.34 Mn |
| Sep 30, 2012 | 1.34 Mn |
| Jun 30, 2012 | -1.18 Mn |
| Jun 30, 2012 | -1.18 Mn |
| Mar 31, 2012 | -4.12 Mn |
| Mar 31, 2012 | -4.12 Mn |
| Dec 31, 2011 | 4.39 Mn |
| Dec 31, 2011 | 4.39 Mn |
| Sep 30, 2011 | 681,000.00 |
| Sep 30, 2011 | 681,000.00 |
| Jun 30, 2011 | -133,000.00 |
| Jun 30, 2011 | -133,000.00 |
| Mar 31, 2011 | -1.02 Mn |
| Mar 31, 2011 | -1.02 Mn |
| Dec 31, 2010 | 898,000.00 |
| Dec 31, 2010 | 898,000.00 |
| Sep 30, 2010 | 95,000.00 |
| Sep 30, 2010 | 95,000.00 |